These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3899034)

  • 21. Potential role of postmarketing research.
    Venulet J
    Drugs Exp Clin Res; 1987; 13(11):673-83. PubMed ID: 3443043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Round table: Post-marketing evaluation of fertility-regulating drugs as viewed by the pharmaceutical industry.
    Hum Reprod; 1987 Apr; 2(3):241-63. PubMed ID: 3597744
    [No Abstract]   [Full Text] [Related]  

  • 23. [Notification of possible adverse reactions to drugs in medical publications].
    Laporte JR; Capellà D
    Med Clin (Barc); 1984 Oct; 83(11):474. PubMed ID: 6503426
    [No Abstract]   [Full Text] [Related]  

  • 24. Postmarketing surveillance.
    Oleen MA
    Can J Hosp Pharm; 1987 Oct; 40(5):171-2, 179-80. PubMed ID: 10284449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Revised ADR report permits internal review of drug experience.
    Jeffrey LP
    Pharm Times; 1986 Dec; 52(12):48-50. PubMed ID: 10317827
    [No Abstract]   [Full Text] [Related]  

  • 26. Biological indicator test packs: a survey of user practices.
    Smith DE
    J Healthc Mater Manage; 1988; 6(4):38, 40-2. PubMed ID: 10287653
    [No Abstract]   [Full Text] [Related]  

  • 27. Rational product evaluation.
    Larson E; Maciorowski L
    J Nurs Adm; 1986; 16(7-8):31-6. PubMed ID: 3637222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The desire to regulate: the wish to discover.
    Lasagna L
    Drugs Exp Clin Res; 1987; 13(11):659-64. PubMed ID: 3443041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postmarketing surveillance of adverse drug reactions.
    Castle WM; Lewis JA
    Br Med J (Clin Res Ed); 1984 May; 288(6428):1458-9. PubMed ID: 6426604
    [No Abstract]   [Full Text] [Related]  

  • 30. Postmarketing surveillance methodologies.
    Edlavitch SA
    Drug Intell Clin Pharm; 1988 Jan; 22(1):68-78. PubMed ID: 3280280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postmarketing surveillance of adverse reactions to drugs.
    Rawlins MD
    Br Med J (Clin Res Ed); 1984 Mar; 288(6421):879-80. PubMed ID: 6423125
    [No Abstract]   [Full Text] [Related]  

  • 32. Techniques of postmarketing surveillance. An overview.
    Carson JL; Strom BL
    Med Toxicol; 1986; 1(4):237-46. PubMed ID: 3537618
    [No Abstract]   [Full Text] [Related]  

  • 33. Postmarketing follow-up: physicians have key role.
    Goldsmith MF
    JAMA; 1985 Oct; 254(16):2217. PubMed ID: 4046146
    [No Abstract]   [Full Text] [Related]  

  • 34. Postmarketing surveillance of adverse reactions to drugs.
    Inman WHW
    Br Med J (Clin Res Ed); 1984 Apr; 288(6424):1155-6. PubMed ID: 6424767
    [No Abstract]   [Full Text] [Related]  

  • 35. Discovery of adverse drug reactions. A comparison of selected phase IV studies with spontaneous reporting methods.
    Rossi AC; Knapp DE; Anello C; O'Neill RT; Graham CF; Mendelis PS; Stanley GR
    JAMA; 1983 Apr 22-29; 249(16):2226-28. PubMed ID: 6834622
    [No Abstract]   [Full Text] [Related]  

  • 36. [Contribution of data of efficacy trials to judge the improvement of the medical usefulness of a drug].
    Bouvenot G; Eschwège E
    Therapie; 1992; 47(1):17-9. PubMed ID: 1523589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-marketing surveillance of new drugs.
    Buckley EG
    J R Coll Gen Pract; 1987 Aug; 37(301):337-8. PubMed ID: 3448222
    [No Abstract]   [Full Text] [Related]  

  • 38. The computerized on-line Medicaid pharmaceutical analysis and surveillance system: a new resource for postmarketing drug surveillance.
    Strom BL; Carson JL; Morse ML; LeRoy AA
    Clin Pharmacol Ther; 1985 Oct; 38(4):359-64. PubMed ID: 3899458
    [No Abstract]   [Full Text] [Related]  

  • 39. [Presentation of data in drug surveillance and bases for a decision].
    Lagier G
    Rev Med Interne; 1986 Nov; Spec No():41-4. PubMed ID: 3809779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Which drug surveillance for a non-steroidal anti-inflammatory agent?].
    Netter P; Bannwarth B; Royer RJ
    Presse Med; 1987 Sep; 16(31):1503-4. PubMed ID: 2958814
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.